Abstract
Objectives: Stem cell therapy is a promising approach treating end- stage heart failure. Mesenchymal stem-cells (MSCs) injected intra- myocardially differenciate into capillaries while glandular stem cells, derived from pancreas, parotis or submandibularis, transform into cardio- myocytes. Major questions of applying stem cell therapy in a failing myocardium are the intra-myocardial homing and the development of gap junctions. The following study will deal with these 2 questions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
